Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Rethinking trials: the pros and cons of protocol amendments

R&D protocol amendments

Protocol amendments occur often and can be beneficial, but the steps involved can be complex

Strengthening business competition and reducing anti-competitive practices

Drug pricing and competition How the CMA is tackling high prices for essential drugs

Pharmaceutical innovation in the APAC region

APAC mapA first-of-its-kind study paints a vivid picture of the APAC region’s future

The long and winding road to asthma breakthroughs

GSK Steve YanceyRespiratory biologics are booming thanks to scientists who refused to be derailed by early research setbacks

Combining hard technology with human skills

Nov coverChris Ross explores why pharma’s multichannel maturity isn’t just about hard technology – success depends on ‘human’ enablers

More Intelligence articles

PME supplements

The Gallery

A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.

More from the gallery

Webinars

Beyond the Blame Game: Improving Patient, Physician, Pharma Relations

We often hear patients report a lack of ‘connection’ with their physician, and where lifestyle plays a role in the development of a disease, such as obesity or type 2

Transforming Access to Medicines Through Patient-Centric Solutions

As medicines access evolves and pharmaceutical companies take an increasingly nuanced approach to it, it’s ever-more important to focus on particular aspects of this area and investigate whether firms are

The Future of Marketing in Life Sciences: Is your function fit for purpose

The healthcare landscape is rapidly changing as it responds to a multitude of well-known issues. Coupled with emerging digital technologies, these drivers are shaping the industry, moving it towards a

The Power of Storytelling in Health: Friend or Foe?

With traditional media moving online, and the era of social media driving stories through the ethernet, never has a ‘story’ been more impactful.

Country reports

The death of the cancer drugs fund?

UK flagNHS England's siloed budget and its uncertain future

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge

Communiqué case studies

Career advice from jobs.pmlive.com

Unlocking intrapreneurial talent

Overcoming flaws in leadership development with pharma companies

PMLiVE Jobs articleGo to the PMLiVE Jobs website

So you want to be a medical writer?

Key skills and qualities for a career in medical writing

PMLiVE Jobs articleGo to the PMLiVE Jobs website

Lessons learned from mentoring

Lessons learned from mentoring A good match produces the best results

PMLiVE Jobs articleGo to the PMLiVE Jobs website

Senior execs are going dark on social media

Social media cartoon Senior industry figures are taking an ‘ex-directory’ network

PMLiVE Jobs articleGo to the PMLiVE Jobs website

Video

Webinar: Customer engagement design

Customer engagement design pharma Webinar: Customer engagement design

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

The impact of new technology on healthcare

Mindy Daeschner PSHealth PMLiVE speaks to Mindy Daeschner, director of healthcare technology company PSHealth.

White papers

Using human insights to push healthcare communications forward

This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives

RWE Blog 4: The place of real-world evidence in the market access strategy

The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in

RWE Blog 3: Is real-world evidence the holy grail

We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use

What do Healthcare Professionals think about the inclusion of remote selling techniques?

Evolving to a digitally focused pharma / healthcare company - an organisational roadmap

PMHub Videos and Podcasts

More intelligence

Round Tables

New models of NHS care – new models of Pharma response?

Digital Handbook

Digital editions

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Quick links

Infographics

Multimedia